Jan 5, 2026 | Client News
Brio Financial Group congratulates our client, Pelthos Therapeutics Inc. (hashtag#NYSE American: hashtag#PTHS), on its acquisition of Xeglyze® (abametapir), an FDA approved prescription topical treatment for head lice, from Hatchtech Pty Ltd., for $1.8 million....
Dec 4, 2025 | Client News
Brio Financial Group is pleased to announce the successful $300 million initial public offering of our client, New America Acquisition I Corp. The company priced 30,000,000 units at $10.00 per unit, with each unit consisting of one share of Class A common stock and...
Nov 10, 2025 | Client News
Congrats to Brio Financial Group client – Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to...
Sep 17, 2025 | Client News
Brio Financial congratulates our client NMP Acquisition Corp. (Nasdaq: #NMPU) on filing for a $100 million IPO. Led by Melanie Figueroa (CEO) and Nadir Ali (CFO) of Next Move Partners, NMP Acquisition brings seasoned SPAC leadership to the Nasdaq with a clear strategy...
Aug 25, 2025 | Client News
Pure Lithium’s Brine-to-Battery Technology Wins 2025 Green Chemistry Challenge Award Congratulations to our client, Pure Lithium Corporation, on receiving the 2025 Green Chemistry Challenge Award from the U.S. Environmental Protection Agency and the American Chemical...
Jul 14, 2025 | Client News
Brio Financial Group is pleased to announce the successful $152 million IPO of our client, Globa Terra Acquisition Corp. The company is now trading on Nasdaq under the symbol GTERU, following the pricing of 15,200,000 units at $10.00 per unit. Globa Terra Acquisition...
